Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 477

Similar articles for PubMed (Select 17667804)

1.

Influence of donor histology on outcome in patients undergoing transplantation for hepatitis C.

Bahra M, Jacob D, Neumann UP, Spies F, Langrehr JM, Berg T, Neuhaus R, Neuhaus P.

Transplantation. 2007 Jul 27;84(2):144-8.

PMID:
17667804
2.

[Old donors in liver transplantation for chronic hepatitis C].

Aguilera V, Ponce M, Berenguer M, Moreno R, Rayón JM, Sanjuán F, Prieto M, Mir J.

Rev Esp Enferm Dig. 2007 Oct;99(10):581-7. Spanish.

3.

Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.

Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, Schiano TD.

Liver Transpl. 2006 Oct;12(10):1496-503.

4.

Positive serum cryoglobulin is associated with worse outcome after liver transplantation for chronic hepatitis C.

Rayhill SC, Kirby PA, Voigt MD, La Brecque DR, Lutz CT, Katz DA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Heisey D, Wu YM, Schmidt WN.

Transplantation. 2005 Aug 27;80(4):448-56.

PMID:
16123717
5.

Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus.

Mutimer DJ, Gunson B, Chen J, Berenguer J, Neuhaus P, Castaing D, Garcia-Valdecasas JC, Salizzoni M, Moreno GE, Mirza D.

Transplantation. 2006 Jan 15;81(1):7-14.

PMID:
16421468
6.

Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up.

Zein NN, Rakela J, Poterucha JJ, Steers JL, Wiesner RH, Persing DH.

Liver Transpl Surg. 1995 Nov;1(6):354-7.

PMID:
9346611
7.

Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.

Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Rosser BG, Satyanarayana R, Grewal HP, Hewitt WR, Harnois DM, Crook JE, Steers JL, Dickson RC.

Transplantation. 2004 Jan 15;77(1):84-92.

PMID:
14724440
8.

Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.

Neumann UP, Berg T, Bahra M, Seehofer D, Langrehr JM, Neuhaus R, Radke C, Neuhaus P.

J Hepatol. 2004 Nov;41(5):830-6.

PMID:
15519657
9.

To transplant or not to transplant recurrent hepatitis C and liver failure.

Forman LM.

Clin Liver Dis. 2003 Aug;7(3):615-29. Review.

PMID:
14509530
10.

Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation.

Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW.

Liver Transpl. 2003 Oct;9(10):1053-61.

11.

Liver transplantation using young pediatric donor grafts in adults with hepatitis C infection.

Ghabril M, Dickson RC, Krishna M, Bonatti H, Aranda-Michel J, Keaveny AP, Satyanarayana R, Hewitt W, Hughes CB, Nguyen JH.

Transplantation. 2009 Apr 27;87(8):1174-9. doi: 10.1097/TP.0b013e31819ea72f.

PMID:
19384164
12.

Impact of donor histology on survival following liver transplantation for chronic hepatitis C virus infection: a Scandinavian single-center experience.

Ydreborg M, Westin J, Lagging M, Castedal M, Friman S.

Scand J Gastroenterol. 2012 Jun;47(6):710-7. doi: 10.3109/00365521.2012.672592. Epub 2012 Mar 27.

PMID:
22452366
13.

Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.

Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, Neuhaus P.

Transplantation. 2004 Jan 27;77(2):226-31.

PMID:
14742986
14.

Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.

Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN.

Transplantation. 2007 Aug 15;84(3):331-9.

PMID:
17700157
15.

Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.

Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, Oike F, Ueda M, Egawa H, Tanaka K.

Transplantation. 2006 Feb 15;81(3):350-4.

PMID:
16477219
16.

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.

Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.

Liver Transpl. 2007 May;13(5):733-40.

17.

Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.

Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M.

Liver Transpl. 2009 Jun;15(6):619-28. doi: 10.1002/lt.21761.

18.

The outcome of liver grafts procured from hepatitis C-positive donors.

Velidedeoglu E, Desai NM, Campos L, Olthoff KM, Shaked A, Nunes F, Zeldin G, Stewart C, Blumberg E, Abrams J, Markmann JF.

Transplantation. 2002 Feb 27;73(4):582-7.

PMID:
11889435
19.

Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation.

Selzner M, Kashfi A, Selzner N, McCluskey S, Greig PD, Cattral MS, Levy GA, Lilly L, Renner EL, Therapondos G, Adcock LE, Grant DR, McGilvray ID.

Liver Transpl. 2009 Oct;15(10):1288-95. doi: 10.1002/lt.21828.

20.

Hepatitis C transmission and infection by orthotopic heart transplantation.

Pfau PR, Rho R, DeNofrio D, Loh E, Blumberg EA, Acker MA, Lucey MR.

J Heart Lung Transplant. 2000 Apr;19(4):350-4.

PMID:
10775815
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk